Evan C Guillemin's most recent trade in Mesa Laboratories, Inc. was a trade of 431 Common Stock done . Disclosure was reported to the exchange on Sept. 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 431 | 29,207 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 01 Sep 2022 | 431 | 0 | - | - | Restricted Stock Units - 6 | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 196.12 per share. | 18 Aug 2022 | 3,692 | 28,776 (0%) | 0% | 196.1 | 724,075 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 18 Aug 2022 | 1,320 | 1,450 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.56 per share. | 18 Aug 2022 | 1,320 | 31,108 (0%) | 0% | 70.6 | 93,139 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 18 Aug 2022 | 1,000 | 450 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.66 per share. | 18 Aug 2022 | 1,000 | 32,108 (0%) | 0% | 122.7 | 122,660 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 18 Aug 2022 | 360 | 90 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 142.40 per share. | 18 Aug 2022 | 360 | 32,468 (0%) | 0% | 142.4 | 51,264 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 30 | 30 | - | - | Restricted Stock Unit - 1 | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 30 | 29,788 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 310.61 per share. | 02 Dec 2021 | 2,320 | 29,758 (0%) | 0% | 310.6 | 720,615 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 02 Dec 2021 | 1,200 | 3,890 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.70 per share. | 02 Dec 2021 | 1,200 | 30,958 (0%) | 0% | 89.7 | 107,640 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 02 Dec 2021 | 1,000 | 2,770 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 97.78 per share. | 02 Dec 2021 | 1,000 | 32,078 (0%) | 0% | 97.8 | 97,780 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.51 per share. | 02 Dec 2021 | 120 | 31,078 (0%) | 0% | 58.5 | 7,021 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 02 Dec 2021 | 120 | 3,770 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 431 | 431 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 308 | 0 | - | - | Restricted Stock Units - 5 | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 308 | 29,758 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 282.18 per share. | 16 Jul 2021 | 720 | 29,450 (0%) | 0% | 282.2 | 203,170 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 256.36 per share. | 16 Jun 2021 | 720 | 30,170 (0%) | 0% | 256.4 | 184,579 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 265 | 0 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 265 | 30,890 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 30 | 60 | - | - | Restricted Stock Units -1 | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 30 | 30,625 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 244.25 per share. | 17 May 2021 | 720 | 30,595 (0%) | 0% | 244.3 | 175,860 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 253.77 per share. | 16 Apr 2021 | 720 | 31,315 (0%) | 0% | 253.8 | 182,714 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 269.48 per share. | 16 Mar 2021 | 720 | 32,035 (0%) | 0% | 269.5 | 194,026 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 281.52 per share. | 16 Feb 2021 | 3,600 | 32,755 (0%) | 0% | 281.5 | 1,013,472 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2020 | 477 | 0 | - | - | Restricted Stock Units - 3 | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2020 | 477 | 36,355 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2020 | 308 | 308 | - | - | Restricted Stock Unit - 5 | |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 274.30 per share. | 13 Nov 2020 | 2,050 | 35,878 (0%) | 0% | 274.3 | 562,315 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.50 per share. | 13 Nov 2020 | 1,000 | 37,728 (0%) | 0% | 50.5 | 50,500 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 13 Nov 2020 | 1,000 | 5,290 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 13 Nov 2020 | 850 | 6,290 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.20 per share. | 13 Nov 2020 | 850 | 36,728 (0%) | 0% | 29.2 | 24,820 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.85 per share. | 13 Nov 2020 | 200 | 37,928 (0%) | 0% | 51.9 | 10,370 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 13 Nov 2020 | 200 | 5,090 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Sale of securities on an exchange or to another person at price $ 273.77 per share. | 12 Nov 2020 | 950 | 35,878 (0%) | 0% | 273.8 | 260,082 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 12 Nov 2020 | 800 | 5,090 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.85 per share. | 12 Nov 2020 | 800 | 36,828 (0%) | 0% | 51.9 | 41,480 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.20 per share. | 12 Nov 2020 | 150 | 36,028 (0%) | 0% | 29.2 | 4,380 | Common Stock |
| Mesa Laboratories Inc | Evan C. Guillemin | Director | 12 Nov 2020 | 150 | 5,890 | - | - | Non Qualified Stock Option |